Log In
Print
BCIQ
Print
Print this Print this
 

Raplixa (formerly Fibrocaps)

  Manage Alerts
Collapse Summary General Information
Company The Medicines Co.
DescriptionDry powder topical fibrin sealant composed of fibrinogen and thrombin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationBleeding
Indication DetailsTreat mild to moderate surgical bleeding
Regulatory Designation

EU - Standard Review (Treat mild to moderate surgical bleeding)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$240.0M

$10.0M

$140.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today